GO:0010564 regulation of cell cycle process: Checkpoint Control, Genes, Functions and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0010564 (regulation of cell cycle process) describes any process that modulates the biochemical and morphological phases of successive cell or nuclear replication events.
Cell cycle checkpoints are the principal regulatory modules that ensure order and fidelity of cell cycle transitions.
Ubiquitination machinery, including E3 ligases and deubiquitinases, provides reversible control of cell cycle regulators and is frequently dysregulated in cancer.
Embryonic cell cycle regulation in mammals relies on maternal and zygotic control of division timing and checkpoint strength.
Kinetochore assembly and checkpoint signaling are core structural and signaling components of mitotic regulation.
Checkpoint inhibitors are actively explored in radiation oncology to selectively sensitize tumor cells.

Description

GO:0010564, regulation of cell cycle process, is a biological process ontology term that captures any process modulating the progression of biochemical and morphological phases and events occurring during successive cell replication or nuclear replication events. In practice, this term encompasses checkpoint signaling, ubiquitin-dependent proteolysis of cell cycle regulators, and developmental control of division cycles. Understanding this term is essential because dysregulation of cell cycle control underlies cancer, developmental disorders, and responses to genotoxic therapy.

regulation of cell cycle process At A Glance

GO ID GO:0010564
GO term regulation of cell cycle process
Ontology biological_process
Synonym none
Major function Modulation of biochemical and morphological phases of successive cell or nuclear replication events
Example regulators Checkpoint kinases, E3 ubiquitin ligases, deubiquitinases, kinetochore components
Disease relevance Cancer, developmental disorders, radiation response
Research methods CRISPR knockout, point mutation, knock-in, overexpression, library screening, bioinformatics

What Is GO:0010564?

According to the QuickGO definition, GO:0010564 refers to any process that modulates a cellular process involved in the progression of biochemical and morphological phases and events that occur in a cell during successive cell replication or nuclear replication events. In other words, it is the regulatory layer that adjusts the timing, order, and fidelity of cell cycle transitions rather than the core execution machinery itself.

Why Is regulation of cell cycle process Important in Cell Biology?

Regulation of cell cycle process is central to genome stability and tissue homeostasis, and its perturbation is a hallmark of cancer and developmental disease. Because checkpoints and ubiquitin-dependent degradation control the order and timing of cell cycle transitions, experimental manipulation of these regulators is a mainstay of cancer biology and regenerative research.
Checkpoints prevent premature entry into mitosis and ensure proper chromosome segregation.
Ubiquitination machinery controls the abundance of cyclins, CDK inhibitors, and mitotic regulators.
Embryonic cell cycle regulation determines preimplantation development and ploidy control.
Kinetochore function is essential for spindle attachment and checkpoint signaling.
Checkpoint inhibitors are being tested to enhance radiation sensitivity in tumors.
Polyploidization in megakaryocytes illustrates developmentally programmed cell cycle remodeling.
Dysregulated cell cycle control contributes to cancer progression and therapy resistance.
Cell cycle regulation is a major target for CRISPR functional genomics screens.

What Happens During regulation of cell cycle process?

Checkpoint signaling at cell cycle transitions
In simple terms: Checkpoints act like quality control gates that pause the cell cycle until each step is completed correctly.
Checkpoint pathways monitor DNA integrity, replication completion, and spindle attachment, delaying cell cycle transitions until errors are resolved. In Saccharomyces cerevisiae, mitotic exit checkpoints coordinate late mitotic events with spindle positioning and chromosome segregation. These signaling modules are conserved and form the core of GO:0010564 regulation.
Ubiquitin-dependent control of cell cycle regulators
In simple terms: Tagging proteins with ubiquitin acts like a molecular disposal label that controls when key cell cycle proteins are removed.
E3 ubiquitin ligases and deubiquitinases dynamically regulate the stability of cyclins, CDK inhibitors, and mitotic effectors, thereby controlling cell cycle progression. Dysregulation of this machinery is frequently observed in cancer and contributes to uncontrolled proliferation.
Developmental and embryonic cell cycle regulation
In simple terms: Early embryos use special timing and checkpoint rules to divide rapidly and correctly.
During mammalian preimplantation development, the embryonic cell cycle is regulated by maternal stores and zygotic gene activation, with distinct checkpoint stringency compared with somatic cells. This developmental regulation ensures proper cleavage divisions and ploidy control.
Kinetochore assembly and mitotic regulation
In simple terms: The kinetochore is the docking station on chromosomes that connects them to the spindle and signals when attachment is correct.
The kinetochore is a multiprotein structure that mediates chromosome-spindle attachment and activates the spindle assembly checkpoint. Its assembly and function are integral to the regulation of mitotic progression within GO:0010564.
Polyploidization and cell cycle remodeling
In simple terms: Some cells intentionally skip or modify normal division steps to become larger and more DNA-rich.
Megakaryocytes undergo polyploidization through modified cell cycle regulation, including endomitosis, which is a developmentally programmed deviation from standard mitotic cycles. This illustrates the flexibility of cell cycle regulation in differentiation.

Key Genes Involved in GO:0010564 regulation of cell cycle process

The following genes and proteins are representative regulators and effectors within GO:0010564, based on the cited literature.
GeneMajor RoleResearch Relevance
CDK1Cyclin-dependent kinase driving mitotic entryCore target for cell cycle arrest studies
CCNB1Cyclin B1, partner of CDK1Regulates mitotic progression
CDC20Activator of anaphase-promoting complexControls mitotic exit
APC/CE3 ubiquitin ligase complexDegrades securin and cyclins
MDM2E3 ligase regulating p53Links cell cycle checkpoints to apoptosis
TP53Checkpoint transcription factorGuardian of the genome
CHEK1Checkpoint kinase 1DNA damage checkpoint effector
CHEK2Checkpoint kinase 2DNA damage response regulator
WEE1Kinase inhibiting CDK1Target for radiation sensitization
PLK1Polo-like kinase 1Mitotic progression regulator
AURKAAurora kinase ASpindle assembly and checkpoint
BUB1Spindle assembly checkpoint kinaseKinetochore signaling
MAD2L1Spindle checkpoint componentMitotic arrest control
NDC80Kinetochore componentChromosome segregation
CDKN1Ap21, CDK inhibitorCell cycle arrest and senescence
CDKN2Ap16, CDK inhibitorCell cycle restriction point
UBE2CUbiquitin-conjugating enzymeMitotic ubiquitination

How Is regulation of cell cycle process Regulated?

Regulation of cell cycle process is itself controlled by checkpoint kinases, ubiquitin ligases, and developmental cues. For example, WEE1 kinase inhibits CDK1 to prevent premature mitotic entry, while CDC25 phosphatases reverse this inhibition. Ubiquitin-dependent degradation of cyclins and CDK inhibitors provides irreversible transitions. In embryos, maternal mRNA and protein stores temporally regulate cell cycle progression.

regulation of cell cycle process and Human Disease

GeneDisease / BiologyPotential Experimental Model
TP53Li-Fraumeni syndrome, many cancersKnockout and point mutation cell lines
CDKN2AMelanoma, pancreatic cancerKnockout and overexpression models
CHEK1Cancer therapy resistanceKnockout and inhibitor sensitivity assays
WEE1Radiation sensitizationKnockout and point mutation models
CDC20Aneuploidy and cancerKnockout and knock-in models
Cancer and uncontrolled proliferation
Dysregulation of cell cycle checkpoints and ubiquitin machinery leads to genomic instability and uncontrolled proliferation, hallmark features of cancer. Mutations in TP53, CDKN2A, and checkpoint kinases are common in human tumors.
Radiation response and therapy resistance
Checkpoint inhibitors such as WEE1 and CHEK1 inhibitors are being developed to abrogate radiation-induced cell cycle arrest and sensitize tumor cells to DNA damage.
Developmental and ploidy disorders
Altered regulation of embryonic cell cycles can result in aneuploidy and developmental failure. Polyploidization defects in megakaryocytes are associated with hematological abnormalities.

From regulation of cell cycle process-Related Genes to Experimental Models

Research QuestionSuitable Model
Does loss of a checkpoint gene abrogate cell cycle arrest?CRISPR knockout
Does a specific phosphorylation site control checkpoint function?Point mutation knock-in
Does a tag affect protein localization during mitosis?Tagged knock-in
Does overexpression drive proliferation?Overexpression
Which genes regulate cell cycle in a genome-wide screen?CRISPR library screening
What pathways are enriched among cell cycle regulators?Bioinformatics analysis

How to Study the regulation of cell cycle process Process

MethodWhat It MeasuresTypical Application
Flow cytometryDNA content and cell cycle phaseCheckpoint arrest analysis
Live-cell imagingMitotic timing and chromosome dynamicsKinetochore and spindle checkpoint studies
Ubiquitin proteomicsUbiquitinated peptides and substratesE3 ligase target discovery
RNA-seqTranscriptional changesCell cycle gene expression profiling
CRISPR knockout screenGene essentiality and resistanceCell cycle regulator discovery
Bioinformatics pathway enrichmentGO term and pathway overrepresentationFunctional interpretation of hits
Western blotProtein levels and phosphorylationCheckpoint activation validation
Flow cytometry and cell cycle profiling
Flow cytometry with DNA dyes measures cell cycle distribution and checkpoint arrest, providing quantitative readouts of GO:0010564 activity.
Live-cell imaging of mitotic progression
Fluorescent tagging of chromosomes and kinetochores allows real-time monitoring of mitotic timing and checkpoint satisfaction.
Ubiquitin proteomics and degradation assays
Mass spectrometry-based ubiquitin remnant profiling and cycloheximide chase assays identify substrates and dynamics of ubiquitin-dependent cell cycle regulators.
CRISPR functional genomics screens
Pooled CRISPR knockout or activation screens can identify genes that regulate cell cycle progression or checkpoint responses.

How CRISPR Can Be Used to Study GO:0010564 regulation of cell cycle process

Knockout

CRISPR knockout of cell cycle regulators such as CDK1, CHEK1, or WEE1 can reveal their requirement for checkpoint arrest and proliferation.

Point Mutation

Point mutation knock-in of phosphorylation sites or catalytic residues in checkpoint kinases allows precise structure-function analysis.

Knock-in

Tagged knock-in of kinetochore or checkpoint proteins enables live-cell imaging of their localization and dynamics.

Overexpression

Overexpression of cyclins or CDK inhibitors can drive or block cell cycle progression, modeling oncogenic or protective states.

How EDITGENE Supports regulation of cell cycle process Research

Researchers studying regulation of cell cycle process-related genes often need to determine whether a candidate gene is causally involved in checkpoint control, proliferation, or therapy response. EDITGENE provides the CRISPR tools and services to build such causal models efficiently.
Contact EDITGENE today to design your custom CRISPR model for regulation of cell cycle process research.

Frequently Asked Questions About regulation of cell cycle process

GO:0010564 is a biological process ontology term describing any process that modulates the biochemical and morphological phases of successive cell or nuclear replication events.
Key genes include CDK1, CCNB1, CDC20, APC/C subunits, TP53, CHEK1, CHEK2, WEE1, PLK1, AURKA, BUB1, MAD2L1, and CDKN1A.
Checkpoints monitor DNA integrity and spindle attachment, delaying transitions until errors are resolved.
Ubiquitin ligases and deubiquitinases control the stability of cyclins and CDK inhibitors, driving irreversible cell cycle transitions.
Embryonic cell cycles are controlled by maternal stores and zygotic gene activation, with distinct checkpoint properties.
Cancer, developmental disorders, and therapy resistance are linked to dysregulated cell cycle control.
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of cell cycle regulators.
Flow cytometry, live-cell imaging, ubiquitin proteomics, RNA-seq, and CRISPR screens are commonly used.
The kinetochore mediates chromosome-spindle attachment and activates the spindle assembly checkpoint.
Checkpoint inhibitors abrogate radiation-induced arrest, sensitizing tumor cells to DNA damage.

Conclusion

GO:0010564 regulation of cell cycle process is a central biological process that integrates checkpoint signaling, ubiquitin-dependent proteolysis, and developmental cues to ensure faithful cell division. Its dysregulation is a driver of cancer and a target for therapeutic intervention, making it a rich area for CRISPR-based functional studies.

References

  1. 1. Barnum KJ et al.. 2014. Cell cycle regulation by checkpoints.. Methods Mol Biol 1170:29-40 PMID: 24906307
  2. 2. Matellán L et al.. 2020. Regulation of Mitotic Exit by Cell Cycle Checkpoints: Lessons From Saccharomyces cerevisiae.. Genes (Basel) 11(2) PMID: 32059558
  3. 3. Zou T et al.. 2021. The Involvement of Ubiquitination Machinery in Cell Cycle Regulation and Cancer Progression.. Int J Mol Sci 22(11) PMID: 34072267
  4. 4. Palmer N et al.. 2016. Regulation of the Embryonic Cell Cycle During Mammalian Preimplantation Development.. Curr Top Dev Biol 120:1-53 PMID: 27475848
  5. 6. Cheeseman IM. 2014. The kinetochore.. Cold Spring Harb Perspect Biol 6(7):a015826 PMID: 24984773
  6. 7. Hauge S et al.. 2023. Expanding roles of cell cycle checkpoint inhibitors in radiation oncology.. Int J Radiat Biol 99(6):941-950 PMID: 33877959
  7. 8. Mazzi S et al.. 2018. Megakaryocyte and polyploidization.. Exp Hematol 57:1-13 PMID: 29111429
Contact Us
*
*
*
*
How did you hear about us: